Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB) Proceeding/Conference:Hepatology International | 2015 | ||
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B Journal:New England Journal of Medicine | 2004 | ||
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B Journal:New England Journal of Medicine | 2005 | ||
Responses to peginterferon alfa-2a (40KD) (PEGASYS) treatment are durable in Asian Patients with HBeAg-Negative CHB: 12 month Follow-Up Data from a large Randomised Study Proceeding/Conference:Journal of Gastroenterology and Hepatology | 2006 |